(Live Virtual Event, May 19) On the Front Lines of Heart Failure: Best Practices and Evolving Evidence in Cardiorenal Care for the Multidisciplinary Team
Event Date
Tuesday - May 19, 2026
Location
Virtual Live Event
Event Time
1:00pm - 2:00pm, EST
Completion Time
60 minutes
Specialty
Cardiology, Endocrinology, Family Medicine, Internal Medicine, and Nephrology
Topic(s)
Heart Failure, Cardiorenal
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ and 1.0 ABIM MOC Points
- Nurses — maximum of 1.0 ANCC contact hours
- PA — maximum of 1.0 AAPA Category 1 CME credits
- Pharmacists — 1.0 ACPE contact hours
All other healthcare professionals completing this course will be issued a statement of participation.
Program Overview
Heart failure (HF) is becoming increasingly prevalent and continues to drive significant morbidity and mortality across the full cardiovascular-kidney-metabolic (CKM) continuum, wherein delayed disease recognition, suboptimal treatment selection, and fragmented care patterns each contribute deleterious impacts to the quality and outcomes of cardiorenal care.
In this 60-minute, expert-led virtual session offering CME/CE and MOC credit, multidisciplinary clinicians will gain practical, evidence-based strategies to improve HF management across the cardiorenal spectrum. Through focused insights, practical pearls, and case-based discussion, faculty will translate evolving evidence into real-world clinical decision-making, with an emphasis on early intervention, guideline-concordant treatment, and team-based care.
Participants will explore:
- The growing burden of HF and its intersection with CKM disease
- Key mechanisms of HF pathophysiology, including the central role of aldosterone
- Approaches to early identification and diagnosis, enabling timely initiation of therapy
- Implementation of guideline-directed medical therapy (GDMT) in everyday practice
- Emerging evidence on aldosterone antagonism and its role in cardiorenal care
Designed for the multidisciplinary team, this program emphasizes collaborative, evidence-driven, and patient-centered strategies to optimize outcomes in HF.
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Review the prevalence and clinical impact of heart failure (HF), and its connection to the cardiovascular-kidney-metabolic (CKM) disease continuum.
- Examine the central role of aldosterone in HF pathophysiology and progression—and why it remains a critical therapeutic target.
- Apply best practice approaches for early identification and diagnosis of HF, ensuring rapid initiation of guideline-directed medical therapy (GDMT).
- Integrate patient-centered, guideline-based treatment plans through effective multidisciplinary and interprofessional collaboration.
Faculty
Muthiah Vaduganathan, MD, MPH, FACC, FHFA (Activity Chair)
Cardiologist and Clinical Trialist
Brigham and Women’s Hospital and Harvard Medical School
Muthiah Vaduganathan, MD, MPH, FACC, FHFA, is a cardiologist and clinical trialist at Brigham and Women’s Hospital and Harvard Medical School. He is co-director of the Center for Cardiometabolic Implementation Science at Brigham and Women’s Hospital. He serves as an Associate Editor of JACC and as US national ambassador to the ESC Heart Failure Association. His research focuses on drug development, clinical trials, and implementation of cardio-kidney-metabolic therapies. He has authored or co-authored more than 850 peer-reviewed publications and is recognized as a Clarivate Highly Cited Researcher. He participates on study leadership of ongoing advanced-phase trials in cardio-kidney-metabolism and heart failure.
Stephanie G Barnes, DNP, AGNP-C, CHFN
Nurse Practitioner
Clinical Director for Advanced Heart Failure
Duke University Hospital
Stephanie G Barnes, DNP, AGNP-C, CHFN, is a Nurse Practitioner and the Clinical Director for Advanced Heart Failure at Duke University Hospital. Stephanie received her bachelors in nursing from the University of South Carolina and masters in nursing from UNC Chapel Hill and Doctorate in Nursing Practice from Duke University. Stephanie serves on the Board of Directors of the American Association of Heart Failure Nurses.
Mona Fiuzat, PharmD, FACC, FHFA, FHFSA
Associate Professor of Medicine
Duke University
Mona Fiuzat, PharmD, FACC, FHFA, FHFSA is an Associate Professor of Medicine at Duke University and spent over 10 years at FDA as former Senior Scientific Advisor for FDA, Division of Cardiology and Nephrology (CDER, DCN), and Senior Senior Scientific Advisor to the FDA Commissioner. She previously served as Executive Editor and current editorial consultant for JACC: Heart Failure as well as several other journals including Circulation, Circ: Heart Failure, European Journal of Heart Failure, and JCF. Her clinical research experience has been in clinical trials with a focus on pharmacogenetics in heart failure, and she helped file an NDA for the first proposed pharmacogenetically targeted heart failure drug. She worked in the Heart Failure research program at Duke on a number of key clinical trials as an investigator and steering committee member, and has authored or co-authored over 200 papers in the field of heart failure. Most recently, she serves as a founder and Executive Committee member of the “Heart Failure Collaboratory”, a public-private partnership between government agencies, academicians, patients, societies and payers to improve heart failure research and therapeutic development. She is a former Program Chair for the Heart Failure Society of America’s (HFSA) Scientific Sessions, Membership Co-Chair, Research Network Taskforce, and served on the HFSA Board of Directors including officer roles as HFSA Secretary and Treasurer. She has also served on the ACC Education and Outcomes Committee, and AHA Nominations Committee and currently on the IMPLEMENT-HF Steering Committee. She was the recipient of the 2019 ACC Distinguished Associate Award.
Accreditation Statement
In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician: American Academy of CME, Inc., designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine MOC Credits: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. By claiming MOC points, you are agreeing to have your participation completion information to be shared with the ACCME and the ABIM. Your points will be automatically submitted to the ABIM on your behalf; please allow 6-8 weeks for your points to display on the ABIM website.
Nurse Practitioners and Nurses: American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours (pharmacotherapeutic contact hours pending).
California: Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.
Pharmacists: This activity provides 1.0 ACPE contact hours (0.1 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-26-031-L01-P, Application
Physician Assistants: American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other HCPS
Other members of the care team will receive a certificate of participation.
Click Start Activity Now to Register!